<DOC>
	<DOCNO>NCT00577902</DOCNO>
	<brief_summary>This study conduct define specific nutritional biomarkers nutritional risk course chemoradiation therapy cancer head neck . This prospective , longitudinal observational study focus specific antioxidant B vitamin . The ORAC select index overall antioxidant capacity . We choose evaluate antioxidant status administer antioxidant show reduce chemotherapeutic agent toxicity .</brief_summary>
	<brief_title>Nutritional Risk Mucositis Patients With Head Neck Carcinoma Receiving Chemoradiation</brief_title>
	<detailed_description>The study include 60 , ≥18 year old patient ( gender ) head neck cancer receive concurrent radiation chemotherapy treatment . Patients pathologically proven head neck squamous cell carcinoma , except nasopharynx sinus eligible , evidence metastatic disease . Patients previous chemotherapy radiation treatment exclude . A Karnofsky performance status ≥60 % require . Patients significant cardiac , chest gastrointestinal comorbidities exclude , previous chemotherapy radiation treatment . Patients may receive standard nutritional care , need . This study involve examination patient evaluate mucositis , collection blood sample analysis specific indicator nutritional status completion questionnaire regard food intake functional status . Blood sample collect brief questionnaire diet weight status complete three visit . Visits occur treatment begin , end XRT treatment 4-6 week completion XRT . Assessments presence severity mucositis functional status ( Karnofsky ) do visit . All sample data collection do visit clinic require patient ' treatment . If necessary obtain blood sample central venous catheter , do use aseptic technique perform nurse . In instance , information obtain part project may use reduce side effect therapy .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Mucositis</mesh_term>
	<criteria>Methodology . Patients present UAMS Head Neck Clinic invite participate study accord inclusion criterion list : 1 . Age 18 year , 2 . Pathologically proven squamous cell carcinoma head neck , except nasopharyngeal sinus 3 . Concurrent radiation chemotherapy ( taxotere/carboplatin ) 4 . Karnofsky score over60 5 . Must receive radiation ( IMRT ) /chemotherapy UAMS 6 . No evidence metastatic disease 7 . No significant cardiac , chest , gastrointestinal renal morbidity 8 . No previous chemotherapy radiation If consider eligible agree participate , patient register sign informed consent form . Radiation chemotherapy commence day . IMRT modality radiation allow . Blood sample collect nutritional risk evaluate , use PatientGenerated Subjective Global Assessment tool ( PGSGA ) . The PGSGA blood test perform , end XRT treatment four six week treatment complete .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>head neck cancer</keyword>
</DOC>